2019
DOI: 10.1007/s00418-019-01821-4
|View full text |Cite
|
Sign up to set email alerts
|

Tricellular tight junction protein LSR/angulin-1 contributes to the epithelial barrier and malignancy in human pancreatic cancer cell line

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
33
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 22 publications
(33 citation statements)
references
References 23 publications
0
33
0
Order By: Relevance
“…LSR is the key molecule of the three-cell contact in the normal cell epithelial barrier and cancer cell malignancies [10]. In endometrial cancer and human pancreatic cancer, it has been found that the loss of LSR can induce the migration, invasion, and proliferation of cancer cells [11]. At the same time, LSR can damage the invasive properties of bladder cancer cells [12].…”
Section: Introductionmentioning
confidence: 99%
“…LSR is the key molecule of the three-cell contact in the normal cell epithelial barrier and cancer cell malignancies [10]. In endometrial cancer and human pancreatic cancer, it has been found that the loss of LSR can induce the migration, invasion, and proliferation of cancer cells [11]. At the same time, LSR can damage the invasive properties of bladder cancer cells [12].…”
Section: Introductionmentioning
confidence: 99%
“…Angulin-1 was originally identified as a lipoprotein receptor (LSR) in the liver [51]. The expression of angulin-1 also correlates with colon, bladder, breast, pancreatic, ovarian, and endometrial cancers [106][107][108][109][110][111]. Recently, Hiramatsu et al, developed the functional monoclonal antibody against the extracellular region of human angulin-1 (anti-hLSR mAb (#1-25)) that crossreacted with mouse LSR.…”
Section: Antibodies Against Angulin-1mentioning
confidence: 99%
“…We previously reported that the downregulation of LSR triggered an increase in both the expression of the Hippo pathway transcription factor TEAD and YAP target gene amphiregulin ( AREG ), a known ligand for EGFR 14 . Recently, we showed that the upregulation of AREG was observed by knockdown of LSR in the human pancreatic cancer cell line HPAC and by the downregulation of LSR in the poorly differentiated pancreatic ductal adenocarcinomas (PDAC) 10 . Therefore, the decrease in LSR expression induces downregulation of the epithelial barrier function, resulting in the promotion of cancer cell malignancy, although the precise mechanisms are still unknown.…”
Section: Introductionmentioning
confidence: 99%